norgestrel has been researched along with gestodene in 60 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (30.00) | 18.7374 |
| 1990's | 36 (60.00) | 18.2507 |
| 2000's | 3 (5.00) | 29.6817 |
| 2010's | 3 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corson, SL; Kafrissen, ME | 1 |
| London, RS | 1 |
| Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
| Rebar, RW; Zeserson, K | 1 |
| Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
| Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Refn, H; Schierup, L | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Kuhnz, W | 1 |
| Hümpel, M; Li, QG | 1 |
| Borggaard, B; Kjaer, A; Lebech, AM; Refn, H; Schierup, L | 1 |
| Fotherby, K | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Juchem, M; Pollow, K | 1 |
| Dewsbury, JA; Kirkman, RJ; Loudon, NB | 1 |
| Maltau, JM; Oian, P; Omsjø, IH; Osterud, B | 1 |
| Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Pedersen, LR; Refn, H; Schierup, L | 1 |
| Chez, RA | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Gaspard, UJ; Lepot, MR | 1 |
| Bonnar, J; Carroll, E; Daly, L | 1 |
| Harenberg, J; Kohlmeier, M; Rabe, T; Runnebaum, B; Weicker, H | 1 |
| Skouby, SO | 1 |
| Mall-Haefeli, M | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Gillmer, MD | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Buse, M; Casals-Stenzel, J; Losert, W | 1 |
| Düsterberg, B | 1 |
| Düsterberg, B; Hümpel, M; Speck, U | 1 |
| Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Sobel, NB | 1 |
| Affinito, P; Di Carlo, C; Farace, MJ; Monterubbianesi, M; Nappi, C; Petrillo, G; Primizia, M; Regine, V | 1 |
| Catherino, WH; Jeng, MH; Jordan, VC | 1 |
| DeCherney, A; Speroff, L | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
| Teichmann, A | 1 |
| Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W | 1 |
| Lidegaard, O | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Cao, S; Wang, Z | 1 |
| Stanczyk, FZ | 1 |
| Gross, W; Jung-Hoffmann, C; Kuhl, H; Wiegratz, I | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| del Marmol, V; Gertsen, K; Teichmann, A | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Gruber, D; Lanius, V; Merz, M; Serrani, M; Skřivánek, A | 1 |
| Nelson, AL | 1 |
13 review(s) available for norgestrel and gestodene
| Article | Year |
|---|---|
Comparative review of third-generation progestins.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norgestrel; Norpregnenes | 1992 |
The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners | 1992 |
Characteristics of the new progestogens in combination oral contraceptives.
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1991 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
Topics: Carbohydrate Metabolism; Desogestrel; Drug Evaluation; Female; Humans; Lipid Metabolism; Menstrual Cycle; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners; Proteins | 1989 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
[New progestational hormones].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners | 1988 |
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.
Topics: Androgens; Blood Coagulation; Blood Glucose; Contraceptives, Oral; Desogestrel; Female; Humans; Insulin; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1993 |
[Advances in the research on new generation of oral contraceptive agents].
Topics: Contraceptives, Oral, Synthetic; Humans; Norgestrel; Norpregnenes | 1996 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
Transdermal contraception methods: today's patches and new options on the horizon.
Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 2015 |
22 trial(s) available for norgestrel and gestodene
| Article | Year |
|---|---|
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
Metabolic changes during treatment with two different progestogens.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Fertilization; Hormones; Humans; Levonorgestrel; Lipid Mobilization; Lipids; Menstrual Cycle; Norgestrel; Norpregnenes; Random Allocation; Reference Values | 1990 |
Clinical and hormonal effects of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene.
Topics: Adult; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Radioimmunoassay; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Patient Dropouts; Random Allocation; United Kingdom | 1990 |
Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
Topics: Adult; Blood Coagulation; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1989 |
Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene.
Topics: Adult; Antithrombin III; Apolipoproteins A; Blood Coagulation; Cholesterol, HDL; Contraceptives, Oral, Combined; Factor VII; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Prospective Studies | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
Clinical and metabolic effects of gestodene and levonorgestrel.
Topics: Adolescent; Adult; Blood Glucose; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Stereoisomerism | 1987 |
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Norgestrel; Norpregnenes | 1993 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin | 1996 |
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Reference Values; Triglycerides | 1998 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
Topics: Adolescent; Adult; Amenorrhea; Austria; Contraceptive Agents, Female; Czech Republic; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Mastodynia; Menorrhagia; Menstrual Cycle; Metrorrhagia; Netherlands; Norgestrel; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; Young Adult | 2015 |
25 other study(ies) available for norgestrel and gestodene
| Article | Year |
|---|---|
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women.
Topics: Adult; Contraceptives, Oral; Female; Half-Life; Humans; Japan; Levonorgestrel; Metabolic Clearance Rate; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Femodene/Minulet--how different is gestodene?
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Norpregnenes | 1990 |
Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man.
Topics: Animals; Binding, Competitive; Blood Proteins; Cyproterone; Cyproterone Acetate; Dogs; Female; Humans; Levonorgestrel; Macaca; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Rabbits; Radioimmunoassay; Rats | 1990 |
Potency and pharmacokinetics of gestagens.
Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus | 1990 |
Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Progestogen potency in oral contraceptive pills.
Topics: Breast; Cholesterol, HDL; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
Progestogens with antimineralocorticoid activity.
Topics: Adrenalectomy; Aldosterone; Androstadienes; Androstenes; Animals; Canrenoic Acid; Canrenone; Cyproterone; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Norethindrone; Norgestrel; Norpregnenes; Potassium; Progesterone; Progesterone Congeners; Rats; Rats, Inbred Strains; Sodium; Spironolactone | 1985 |
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dogs; Female; Half-Life; Injections, Subcutaneous; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Oils; Radioimmunoassay; Rats; Solutions; Species Specificity; Time Factors | 1984 |
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
Topics: Administration, Oral; Animals; Biological Availability; Cyproterone; Cyproterone Acetate; Dogs; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Rats; Species Specificity; Stereoisomerism | 1981 |
Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism.
Topics: Base Sequence; Breast Neoplasms; Cell Division; Estradiol; Estrogens; Female; Gene Expression; Humans; In Vitro Techniques; Mifepristone; Molecular Sequence Data; Norgestrel; Norpregnenes; Polyunsaturated Alkamides; Promoter Regions, Genetic; Receptors, Estrogen; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Safety of combined oral contraceptive pills.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism | 1996 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism | 1997 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |